Plaque psoriasis is a chronic skin condition characterized by the formation of raised, inflamed patches covered with silvery-white scales. It is one of the most common types of psoriasis and affects people across different age groups, although it often develops in adulthood. The condition occurs due to an accelerated skin cell production process, which leads to the buildup of cells on the skin surface. These patches can appear on various parts of the body, including the scalp, elbows, knees, and lower back. While not contagious, plaque psoriasis can significantly influence a person’s quality
Plaque psoriasis is a widespread condition affecting over 60 million people globally, with psoriasis treatment playing a crucial role in managing symptoms. In the United States, approximately 8 million people suffer from psoriasis, and up to 30% of them experience plaque psoriasis.
Genetics are a significant factor in plaque psoriasis development. Research published in the Journal of Investigative Dermatology indicates that genetics contribute to around 80% of the risk. Over 60 genes linked to the condition have been identified, primarily those involved in immune function and skin health.
Environmental influences can trigger or worsen plaque psoriasis. Common triggers include stress, skin injuries, and infections. According to the National Psoriasis Foundation, up to 50% of psoriasis patients report stress as a significant trigger. Awareness of these factors is essential for managing the condition.
Certain lifestyle habits, such as smoking and excessive alcohol consumption, can elevate the risk of psoriasis. The Journal of the American Academy of Dermatology notes that smokers are almost twice as likely to develop psoriasis. The risk increases with the number of cigarettes smoked daily.
Some medications can exacerbate psoriasis symptoms. Drugs including lithium, beta-blockers, antimalarials, and nonsteroidal anti-inflammatory drugs (NSAIDs) are known to potentially worsen the condition. Patients should discuss medication impacts with their healthcare providers.
Obesity, particularly in women, is a notable risk factor. A study in the Journal of Investigative Dermatology found that women with a BMI of 30 or higher faced a 63% increased risk of developing psoriasis compared to those with a BMI under 25.
Vitamin D levels may also play a role. Research suggests individuals with psoriasis might have lower levels of vitamin D than those without the condition. However, further studies are necessary to fully understand this relationship.